Get in touch with us to schedule a consultation and discuss your options with our team
The US Food and Drug Administration (FDA) accepted Novo Nordisks (NOV: N) New Drug Application (NDA) submission for an investigational once-daily, 25 mg oral formulation of Wegovy (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major adverse cardiovascular events (MACE) in adults with overweight or obesity and established cardiovascular disease
Cities at Risk of Sinking Across the U.S., the ground beneath many major cities is gradually subsiding
(2) Tkalcevi VI, Cuzi S, Brajsa K, Mildner B, Bokuli A, Situm K, Perovi D, Glojnari I, Parnham MJ
Berberine 20 mg
Natural ways to improve sleep quality While diet plays a vital role in sleep quality and effectiveness, natural methods can also help relieve insomnia